Pascal Schneider
18Patents
6h-index
18Co-inventors
59Inventor score
Filing activity: Jul 24, 2001 → Feb 7, 2018
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7083785B2 | Methods of treatment by administering an anti-BCMA antibody | Chemistry; Metallurgy | 86 | Expired |
| US6869605B2 | BAFF, inhibitors thereof and their use in the modulation of B-cell response | Human Necessities | 32 | Expired |
| US7385032B2 | Bimer or an oligomer of a dimer, trimer, quadromer or pentamer of recombinant fusion proteins | Physics | 30 | Expired |
| US7276241B2 | Methods of treating a tumor that expresses APRIL by administering BCMA | Chemistry; Metallurgy | 15 | Expired |
| US7736657B2 | Fusion constructs containing active sections on TNF ligands | Chemistry; Metallurgy | 10 | Expired |
| US9650430B2 | Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA) | Chemistry; Metallurgy | 6 | Active |
| US8496937B2 | Preparation of isolated agonist anti-EDAR monoclonal antibodies | Chemistry; Metallurgy | 2 | Active |
| US8895003B2 | Pharmaceutical composition comprising EDA-1 Fusion Protein | Chemistry; Metallurgy | 2 | Active |
| US8501177B2 | Treatment of ectodermal dysplasia with EDA1 fusion proteins | Chemistry; Metallurgy | 2 | Active |
| US8828669B2 | Methods of screening for a compound that inhibits the interaction between BAFF and BCMA | Chemistry; Metallurgy | 1 | Active |
| US10494416B2 | Methods of modulating immune responses using BCMA polypeptide | Chemistry; Metallurgy | 1 | Active |
| US9175085B2 | Treatment of X-linked hypohidrotic ectodermal dysplasia with ectodysplasin A agonist | Chemistry; Metallurgy | 0 | Active |
| US10300013B2 | Intra-amniotic administration of EDI200 for the treatment of ectodermal dysplasias | Human Necessities | 0 | Active |
| US10526412B2 | Anti APRIL (a proliferation-inducing ligand) antibodies and their uses for the prognosis and/or diagnosis of cancer | Chemistry; Metallurgy | 0 | Active |
| US8741297B2 | Preparation of isolated agonist anti-EDAR monoclonal antibodies | Chemistry; Metallurgy | 0 | Active |
| US10426819B2 | Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein | Chemistry; Metallurgy | 0 | Active |
| US9695245B2 | Anti-ectodysplasin antibodies | Physics | 0 | Active |
| US9925239B2 | Treatment of X-linked hypohidrotic ectodermal dysplasia with a fusion EDA1 protein | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.